COVID cases dropping in North, South America, health agency says

People wait to receive an AstraZeneca coronavirus disease (COVID-19) vaccine during a vaccination campaign for homeless people, in Rio de Janeiro's downtown, Brazil, May 27, 2021. REUTERS/Ricardo Moraes

People wait to receive an AstraZeneca coronavirus disease (COVID-19) vaccine during a vaccination campaign for homeless people, in Rio de Janeiro’s downtown, Brazil, May 27, 2021. REUTERS/Ricardo Moraes

BRASILIA, Oct 13 (Reuters) – The Pan American Health Organization (PAHO) said on Wednesday that COVID-19 cases are dropping overall in North America but remain high in the American Midwest, Alaska, and Canada’s Northwest Territories, where infection rates are 10 times the national average.

Infections are also dropping across South America, though cases are up in the greater Caracas area of Venezuela, and in parts of Chile’s southernmost regions.

In the Caribbean, Barbados is reporting the highest number of COVID cases and deaths since the pandemic started, with a five-fold increase in COVID infections over the last month, PAHO said.

The regional branch of the World Health Organization called for concerted action in the Americas to help every country reach the WHO’s vaccination coverage target of 40% of their population by the end of this year.

So far, only nine countries in the region have vaccinated 50% of their people, while six – Jamaica, St. Lucia, St. Vincent & the Grenadines, Haiti, Guatemala and Nicaragua – have yet to reach 20% vaccination coverage, according to PAHO.

Without concerted action to increase the vaccination rate and public health measures, it is possible that COVID-19 could become endemic in the region, PAHO Director Carissa Etienne warned in a weekly briefing.

Third dose booster vaccination is recommended, especially for people who have received the Sinovac Biotech and Sinopharm vaccines developed in China that studies have shown to provide less protection for young adults, PAHO assistant director Jarbas Barbosa said.

Booster vaccination should begin with those over the age of 80, followed by those over 60 years with prior medical conditions, and then young adults, he said. Using other vaccines is possible when the original doses are not available, he said.

Reporting by Anthony Boadle; Editing by Jan Harvey
========================================================
Mexican President Andres Manuel Lopez Obrador attends a news conference at the National Palace in Mexico City, Mexico October 7, 2021. Mexico's Presidency/Handout via REUTERS

Mexican President Andres Manuel Lopez Obrador attends a news conference at the National Palace in Mexico City, Mexico October 7, 2021. Mexico’s Presidency/Handout via REUTERS

MEXICO CITY, Oct 13 (Reuters) – Mexico’s President Andres Manuel Lopez Obrador on Wednesday said the World Health Organization (WHO) should certify COVID-19 vaccines in public use, amid fears some vaccinated Mexicans will not be able to enter the United States.

“The WHO must act correctly, without political or ideological tendencies, sticking to the science,” Lopez Obrador said at a regular news conference.

Lopez Obrador’s comments come after the United States said it would only allow people inoculated by WHO-approved vaccines to enter its borders.

Millions of people in Mexico have been vaccinated with Russian and Chinese shots that do not fulfill that criteria. The U.S. on Tuesday said it was reopening its land borders to fully vaccinated travelers.

Russia’s Sputnik V as well as China’s CanSino vaccines are yet to receive approval by the WHO.

Reporting by Ana Isabel Martinez and Raul Cortes; Writing by Drazen Jorgic; Editing by Frank Jack Daniel
==================================================

What you need to know about the coronavirus right now

Staff members in protective suits check proof of negative test results for travellers at an entrance to the Harbin West Railway Station following new local cases of the coronavirus disease (COVID-19) in Harbin, Heilongjiang province, China September 22, 2021. cnsphoto via REUTERS ATTENTION EDITORS – THIS IMAGE WAS PROVIDED BY A THIRD PARTY. CHINA OUT.

Oct 14 (Reuters) – Here’s what you need to know about the coronavirus right now:

Melbourne set for COVID lockdown exit despite record cases

Melbourne will exit months of COVID-19 lockdown next week, helped by a faster-than-expected vaccine uptake, Victoria state Premier Daniel Andrews said on Thursday, ahead of schedule even though daily infections hit a record the same day.

On the worst day of a Delta variant outbreak that began in early August, Victoria logged 2,297 new cases, up from 1,571 the day before and the highest for any Australian state or territory since the pandemic began. Eleven people died, bringing the total toll in the latest outbreak to 125. read more

Indonesia’s Bali reopens to international tourists, but with no flights

Indonesia’s holiday island of Bali reopened to foreign tourists after 18 months of pandemic hiatus on Thursday, but the island is lacking one crucial ingredient: international flights. Though the island’s Ngurah Rai International Airport has carried out simulations preparing for tourists to return, it is not expecting much to happen soon.

Details about the reopening, such as visa requirements and which countries they apply to, have so far been patchy. Indonesia late on Wednesday had confirmed the 19 eligible countries, which include China, India, Japan, South Korea and New Zealand, and several countries from Western Europe and the Arabian Gulf. read more

J&J shot gets better boost from Moderna or Pfizer in NIH study

People who got Johnson & Johnson Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer Inc/BioNTech SE or Moderna Inc, a study run by the National Institutes of Health showed on Wednesday. The preliminary study hasn’t been peer-reviewed and is the latest challenge to J&J’s efforts to use its vaccine as a booster in the United States. read more

More than 450 adults who received initial shots from Pfizer, Moderna, or Johnson & Johnson were part of the study that showed “mixing and matching” booster shots of different types is safe in adults. Moderna’s and Pfizer’s vaccines are based on messenger RNA, while J&J’s uses viral vector technology. Separately, officials on Wednesday said J&J’s regulatory submission for its planned booster raised red flags, including small sample sizes and data based on tests not yet validated. read more

English school return spurred COVID in children

COVID-19 infections in children in England rose in September after schools returned from summer holidays, helping to keep cases high even as there was a fall among adults, a large prevalence study showed on Thursday.

The study found that the epidemic was growing among those under 17, with an estimated reproduction “R” number of 1.18. An R number above 1 implies exponential growth, while a number below 1 implies the epidemic is shrinking. The epidemic was estimated to be shrinking in 18- to 54-year-olds, while it was broadly steady among those over 55. read more

India resumes vaccine exports as domestic stocks build up – officials

India has resumed a small number of COVID-19 vaccine exports and will increase exports significantly in the next few months as domestic stocks build up and most of its large population is inoculated, officials said on Wednesday.

So far about 4 million shots have been exported, the source said, a small amount in proportion to the expansive vaccine diplomacy Prime Minister Narendra Modi’s government launched this year before a second wave of infections forced a halt. read more

Compiled by Karishma Singh; Editing by Ramakrishnan M.